NovoCure Ltd Insider Trading for May 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovoCure Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NovoCure Ltd for May 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12 2020 | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Offic ... | Option Exercise | M | 0.00 | 4,206 | 0 | 8,410 | |
| May 12 2020 | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Offic ... | Sell | S | 63.73 | 1,611 | 102,666 | 15,211 | 16.8 K to 15.2 K (-9.58 %) |
| May 12 2020 | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Offic ... | Buy | M | 63.84 | 4,206 | 268,511 | 16,822 | 12.6 K to 16.8 K (+33.34 %) |
| May 12 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 63.73 | 31,332 | 1,996,726 | 649,958 | 681.3 K to 650 K (-4.60 %) |
| May 11 2020 | NVCR | NovoCure Ltd | Weinberg Uri | Chief Science Offic ... | Option Exercise | M | 0.00 | 1,402 | 0 | 2,803 | |
| May 11 2020 | NVCR | NovoCure Ltd | Weinberg Uri | Chief Science Offic ... | Buy | M | 63.84 | 1,402 | 89,504 | 25,629 | 24.2 K to 25.6 K (+5.79 %) |
| May 11 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 0.00 | 58,767 | 0 | 0 | |
| May 11 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 0.00 | 58,768 | 0 | 58,767 | |
| May 11 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 63.50 | 31,903 | 2,025,872 | 681,290 | 713.2 K to 681.3 K (-4.47 %) |
| May 11 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 63.84 | 58,767 | 3,751,685 | 713,193 | 654.4 K to 713.2 K (+8.98 %) |
| May 11 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 64.74 | 30,993 | 2,006,518 | 654,426 | 685.4 K to 654.4 K (-4.52 %) |
| May 11 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 64.77 | 58,768 | 3,806,403 | 685,419 | 626.7 K to 685.4 K (+9.38 %) |
| May 07 2020 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 62.20 | 1,149 | 71,468 | 100,693 | 101.8 K to 100.7 K (-1.13 %) |
| May 07 2020 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 62.20 | 1,149 | 71,468 | 100,693 | 101.8 K to 100.7 K (-1.13 %) |
| May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 0.00 | 58,768 | 0 | 117,535 | |
| May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 0.00 | 58,768 | 0 | 117,535 | |
| May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 0.00 | 58,768 | 0 | 176,303 | |
| May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 0.00 | 58,768 | 0 | 176,303 | |
| May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 64.15 | 58,768 | 3,769,967 | 626,651 | 567.9 K to 626.7 K (+10.35 %) |
| May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 64.15 | 58,768 | 3,769,967 | 626,651 | 567.9 K to 626.7 K (+10.35 %) |
| May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 64.27 | 29,881 | 1,920,452 | 567,883 | 597.8 K to 567.9 K (-5.00 %) |
| May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 64.27 | 29,881 | 1,920,452 | 567,883 | 597.8 K to 567.9 K (-5.00 %) |
| May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 62.47 | 30,283 | 1,891,718 | 597,764 | 628 K to 597.8 K (-4.82 %) |
| May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 62.47 | 30,283 | 1,891,718 | 597,764 | 628 K to 597.8 K (-4.82 %) |
| May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 61.40 | 58,768 | 3,608,355 | 628,047 | 569.3 K to 628 K (+10.32 %) |
| May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 61.40 | 58,768 | 3,608,355 | 628,047 | 569.3 K to 628 K (+10.32 %) |
| May 06 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 0.00 | 58,768 | 0 | 235,071 | |
| May 06 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 60.48 | 58,768 | 3,554,289 | 569,279 | 510.5 K to 569.3 K (+11.51 %) |
| May 05 2020 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | M | 0.00 | 2,333 | 0 | 2,333 | |
| May 05 2020 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 60.08 | 1,184 | 71,134 | 101,842 | 103 K to 101.8 K (-1.15 %) |
| May 05 2020 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Buy | M | 65.80 | 2,333 | 153,511 | 103,026 | 100.7 K to 103 K (+2.32 %) |